SAN DIEGO--(BUSINESS WIRE)--As part of continuing efforts to improve wound care nationwide, Cure Care, Inc., has recently delivered vaporous hyperoxia therapy (VHT™) units to several hospitals and healthcare facilities. As a result, a greater number of patients will now have access to groundbreaking technology to treat and heal wounds, burns, and scars.
In the past few weeks, VHT™ devices were placed at the following healthcare settings: a major Hospital in East LA; the University of California, San Francisco, where it will be administered by a vascular surgeon; a private podiatry practice in Escondido, CA; an Indian Health Services clinic; and a private plastic surgery and wound treatment center located in Encinitas, CA.
Additionally, last month, Cure Care Inc. placed units at an amputation prevention center in Sherman Oaks, CA. The units being used at the center have elicited extremely positive feedback, as the health staffers are amazed by results from these first treatments. Testimonials from the other trials around the country have prompted similar praise, with one individual referring to the device as a “miracle on wheels.”
As these trials progress, the Company is also beginning studies of VHT™ with an FDA-cleared wound cleanser solution company. More information will be made public as soon as it becomes available.
ABOUT CURE CARE INC.
Cure Care Inc. is a medical device company that delivers advanced solutions for healing chronic wounds using Vaporous Hyperoxia Therapy, as well as improving the overall healing process that follows skin care procedures. For more information, visit www.curecare.com.